In Focus

  • 24 September 2022 Recommended composition of influenza virus vaccines for use in the 2022 Southern Hemisphere Influenza Season announced

    Recommended composition of influenza virus vaccines for use in the 2022 Southern Hemisphere Influenza Season announced

    (Geneva, Switzerland) An advisory group of experts taking part in a virtual meeting organized by the WHO Global Influenza Programme between 13-23 September 2021 analyzed influenza virus surveillance data generated by the WHO Global Influenza Surveillance and Response System (GISRS), and issued on 24 September 2021, recommendations on the composition of the influenza vaccines for the following influenza season.

    These recommendations are used by the national vaccine regulatory agencies and the pharmaceutical companies to develop, produce and license influenza vaccines.

    read more:

  • 22 August 2021 COVID-19 lineages and variants

    COVID-19 lineages and variants

    GISAID’s EpiCoV database employs tools to assign phylogenetic clades and lineages to genetic sequences of the pandemic coronavirus.  One such tool is the Pango nomenclature by Rambaut et al (2020) which takes a granular approach to classify and describe viral evolution with detailed lineages.

    As new lineages become more widespread, additional genetic markers emerge.  Lineage definitions may be updated to allow researchers to track these separately and permit a more fine-grained picture of how a variant is circulating.  When these updates occur, all genomes in EpiCoV undergo reclassification by Pango which can lead to temporary fluctuations in the tallies of variants. Overinterpretation of these changes in numbers should be avoided.   

  • 3 June 2021 First human case of influenza A/H10N3 virus infection

    First human case of influenza A/H10N3 virus infection

    On May 28, 2021 a resident of the City of Zhenjiang in Jiangsu Province, China, was diagnosed with an influenza A/H10N3 virus infection. This is the first human case of infection with a low pathogenic avian influenza virus of this subtype. How the person was infected is unclear. There is no evidence that the virus spreads easily between humans. A/H10 influenza viruses are abundant in wild birds globally, and occasionally transmit to poultry.

    The whole genome sequence of the virus, A/Jiangsu/428/2021, was released rapidly via the GISAID Initiative by the Jiangsu Provincial Center for Disease Control and Prevention in Nanjing (EPI_ISL_2379892).

    > read more

  • 29 January 2021 Additional closely related bat CoVs identified in Cambodia

    Phylogenetic tree of animal coronaviruses closely related to the pandemic human virus

    Additional closely related bat CoVs identified in Cambodia

    The Virology Unit of the Institut Pasteur du Cambodge has recently submitted the full genome sequences for 2 bat coronaviruses from samples taken from bats in 2010 in the Steung Treng province of Cambodia; they appear to join the list of coronaviruses that are closely related to the current pandemic virus.

    Other potential precursors known so far include bat coronaviruses from caves in Yunnan (Southern China), sampled in 2013 and 2019, and samples derived from pangolins in Southern China from 2017 and 2019.

    see: Vibol Hul et al (2021) A novel SARS-CoV-2 related coronavirus in bats from Cambodia

  • CBD Study finds GISAID might provide useful lessons and insight to ABS discussion

    CBD Study finds 'GISAID might provide useful lessons and insight to ABS discussions'

    A peer-reviewed fact-finding and scoping study on digital sequence information on genetic resources in the context of the Convention on Biological Diversity and the Nagoya Protocol, highlights key advantages of GISAID’s sharing mechanism and a fair and equitable benefit-sharing resulting from access to data.

    With the core principals of timely international sharing of health data for protecting populations against lethal infectious disease outbreaks and adherence to scientific etiquette of acknowledgement of the source of data has resulted in global trust and confidence in GISAID. 

    > download the fact-finding & scoping study

  • 19 May 2017 G20 Health Ministers

    G20 Health Ministers recognize the importance of GISAID in regard to virus data sharing

    At the invitation of Germany, the first meeting of Health Ministers of the Group of Twenty leading industrialized and emerging economies (G20) took place in Berlin between 19-20 May 2017.

    Under the banner of “Together Today for a Healthy Tomorrow – Joint Commitment for Shaping Global Health”, the two-day meeting focused on combating global health hazards. In their Berlin Declaration, the G20 Health Ministers recognize the importance of the Global Initiative on Sharing All Influenza Data (GISAID).

    > read more
    > The Berlin Declaration of the G20 Health Ministers (2017)

hCoV-19 Submission Tracking

hCoV-19 Tracking of Variants

Public-Private Partnerships of the GISAID Initiative

The GISAID Initiative involves public-private-partnerships between the Initiative's administrative arm Freunde of GISAID e.V., a registered non-profit association, and governments of the Federal Republic of Germany, the official host of the GISAID platform, Singapore and the United States of America, with support from private and corporate philanthropy. 

Genomic epidemiology of hCoV-19

hCoV-19 data sharing via GISAID

4,383,873

genome sequence submissions

 

CoronaTrend

The University of Hong Kong (Hong Kong)
Prevalence of different mutations across different lineages

assayM

King Abdullah University of Science & Technology (Saudi Arabia)
Track sensitivity of RT-PCR primers on variants


CoV-Spectrum

Computational Evolution Group, ETH Zurich (Switzerland)
Fully interactive platform to explore and monitor variants of SARS-CoV-2

CoVerage

Helmholtz Centre for Infection Research (Germany)
Epidemiological dynamics of SARS-CoV-2 lineages

CovidTag 

IrsiCaixa AIDS Research Institute (Spain)
Average weekly hCoV-19 variants counts in Spain and Regions

CoVGlobe

The Francis Crick Institute (United Kingdom)
Aggregate three-week rolling averages of lineages in different locations

Regeneron COVID-19 Dashboard

Molecular Profiling & Data Science and Bioinformatics Core Services (USA)
Track current and emerging SARS-CoV-2 variants with customizable visualizations

Outbreak.Info Mutation Situation Reports

The Andersen Lab at Scripps Research (USA)
Tracking the prevalence of several lineages or sets of mutations within the hCoV-19 genome

CoVariants

University of Bern (Switzerland)
SARS-CoV-2 variants and mutations of interest

Covid-Miner

Regina Elena National Cancer Institute (Italy)
Detect the emergence and geographical distribution of hCoV-19 Spike protein genetic varian
ts

COVID-19 CoV Genetics Browser

Broad Institute of MIT and Harvard (USA)
Track transmission, evolution, emergence, immune interactions, diagnostics, therapeutics & vaccines


CoronaTrend

The University of Hong Kong (Hong Kong)
Prevalence of different mutations across different lineages


assayM

King Abdullah University of Science & Technology (Saudi Arabia)
Track sensitivity of RT-PCR primers on variants


Wisconsin Genomic Dashboard

Wisconsin Department of Health Services (USA)
Summary reports on sequencing and variants of SARS-CoV-2 (hCoV-19)

CoV-Spectrum

Computational Evolution Group, ETH Zurich (Switzerland)
Fully interactive platform to explore and monitor variants of SARS-CoV-2

CoVerage

Helmholtz Centre for Infection Research (Germany)
Epidemiological dynamics of SARS-CoV-2 lineages

CovidTag 

IrsiCaixa AIDS Research Institute (Spain)
Average weekly hCoV-19 variants counts in Spain and Regions

CoVGlobe

The Francis Crick Institute (United Kingdom)
Aggregate three-week rolling averages of lineages in different locations

Regeneron COVID-19 Dashboard

Molecular Profiling & Data Science and Bioinformatics Core Services (USA)

Mutation Situation Reports

The Andersen Lab at Scripps Research (USA)
Tracking the prevalence of several lineages or sets of mutations within the hCoV-19 genome

CoVariants

University of Bern (Switzerland)
SARS-CoV-2 variants and mutations of interest

Covid-Miner

Regina Elena National Cancer Institute (Italy)
Detect the emergence and geographical distribution of hCoV-19 Spike protein genetic varian
ts

COVID-19 CoV Genetics Browser

Broad Institute of MIT and Harvard (USA)
Track transmission, evolution, emergence, immune interactions, diagnostics, therapeutics & vaccines